Literature DB >> 27060228

Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.

Can Küçük1, Xiaozhou Hu2, Qiang Gong3, Bei Jiang3, Adam Cornish4, Philippe Gaulard5, Timothy McKeithan3, Wing C Chan6.   

Abstract

Natural killer/T-cell lymphoma (NKTCL) is a rare, aggressive form of non-Hodgkin lymphoma that is generally incurable at more advanced stages with systemic involvement. Clonal diagnostic markers (eg, unique T- or B-cell receptor rearrangements) are not available for NKTCLs. Killer cell immunoglobulin like receptors (KIRs) are a family of type I transmembrane glycoproteins involved in the inhibition or activation of NK cells. A restricted expression profile of KIRs has been proposed as clonal markers of NK-cell proliferations. Here we evaluated the transcription profile of all KIR family genes and C-type lectin receptor genes using RNA sequencing on NKTCL cases (n = 17) and NK-cell lines (n = 3). The expression of all KIRs tended to be markedly reduced or absent in NKTCL, except for the KIR family member killer Ig-like receptor 2DL4 (KIR2DL4; alias CD158D), which was selectively overexpressed in the majority (59%) of cases. No specific expression pattern was observed for C-type lectin receptors. KIR2DL4 is an unusual member of the KIR family that recognizes human leukocyte antigen G and mediates NK-cell activation through inducing proliferation and survival pathways such as AKT and NF-κB. Stable knockdown of KIR2DL4 in two malignant NK-cell lines with high KIR2DL4 expression significantly reduced cell growth. Selective overexpression of KIR2DL4 and down-regulation of inhibitory KIRs may contribute to NKTCL pathogenesis.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27060228      PMCID: PMC4901131          DOI: 10.1016/j.ajpath.2016.02.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  MiXCR: software for comprehensive adaptive immunity profiling.

Authors:  Dmitriy A Bolotin; Stanislav Poslavsky; Igor Mitrophanov; Mikhail Shugay; Ilgar Z Mamedov; Ekaterina V Putintseva; Dmitriy M Chudakov
Journal:  Nat Methods       Date:  2015-05       Impact factor: 28.547

2.  Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas.

Authors:  C W Lin; W H Lee; C L Chang; J Y Yang; S M Hsu
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.

Authors:  Siok-Bian Ng; Viknesvaran Selvarajan; Gaofeng Huang; Jianbiao Zhou; Andrew L Feldman; Mark Law; Yok-Lam Kwong; Norio Shimizu; Yoshitoyo Kagami; Katsuyuki Aozasa; Manuel Salto-Tellez; Wee-Joo Chng
Journal:  J Pathol       Date:  2011-01-05       Impact factor: 7.996

4.  KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules.

Authors:  S M Shahjahan Miah; Tracey L Hughes; Kerry S Campbell
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

Review 5.  Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

Authors:  Amanda K Purdy; Kerry S Campbell
Journal:  Cancer Biol Ther       Date:  2009-12-28       Impact factor: 4.742

6.  Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells.

Authors:  Y Fukushima; Y Oshika; M Nakamura; T Tokunaga; H Hatanaka; Y Abe; H Yamazaki; H Kijima; Y Ueyama; N Tamaoki
Journal:  Int J Mol Med       Date:  1998-09       Impact factor: 4.101

Review 7.  Progress in understanding and managing natural killer-cell malignancies.

Authors:  Kazuo Oshimi
Journal:  Br J Haematol       Date:  2007-10-03       Impact factor: 6.998

Review 8.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

9.  KIR2DL4 (CD158d): An activation receptor for HLA-G.

Authors:  Sumati Rajagopalan; Eric O Long
Journal:  Front Immunol       Date:  2012-08-20       Impact factor: 7.561

10.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences.

Authors:  Jeremy Goecks; Anton Nekrutenko; James Taylor
Journal:  Genome Biol       Date:  2010-08-25       Impact factor: 13.583

View more
  5 in total

1.  Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support.

Authors:  Galyna Bondar; Ryan Togashi; Martin Cadeiras; Joanna Schaenman; Richard K Cheng; Lindsay Masukawa; Josephine Hai; Tra-Mi Bao; Desai Chu; Eleanor Chang; Maral Bakir; Sophie Kupiec-Weglinski; Victoria Groysberg; Tristan Grogan; Joseph Meltzer; Murray Kwon; Maura Rossetti; David Elashoff; Elaine Reed; Pei Pei Ping; Mario C Deng
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

2.  Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis.

Authors:  Yusuke Takei; Chiyuki Ueshima; Tatsuki R Kataoka; Masahiro Hirata; Akihiko Sugimoto; Mariyo Rokutan-Kurata; Koki Moriyoshi; Kazuo Ono; Ichiro Murakami; Sanju Iwamoto; Hironori Haga
Journal:  Oncotarget       Date:  2017-06-06

Review 3.  Advances in multiple omics of natural-killer/T cell lymphoma.

Authors:  Jie Xiong; Wei-Li Zhao
Journal:  J Hematol Oncol       Date:  2018-12-04       Impact factor: 17.388

Review 4.  Killer Immunoglobulin-Like Receptor 2DL4 (CD158d) Regulates Human Mast Cells both Positively and Negatively: Possible Roles in Pregnancy and Cancer Metastasis.

Authors:  Tatsuki R Kataoka; Chiyuki Ueshima; Masahiro Hirata; Sachiko Minamiguchi; Hironori Haga
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

Review 5.  DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses.

Authors:  Huimin Dan; Shanshan Zhang; Yongning Zhou; Quanlin Guan
Journal:  Onco Targets Ther       Date:  2019-12-12       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.